F, G., B, B., & F, S. (2024). Reliability assessment of methylthioadenosine phosphorylase immunohistochemistry as a surrogate biomarker for CDKN2A homozygous deletion in adult-type IDH-mutant diffuse gliomas. Journal of neuropathology and experimental neurology, 83(2), 107. https://doi.org/10.1093/jnen/nlad109
Chicago Style (17th ed.) CitationF, Gundogdu, Babaoglu B, and Soylemezoglu F. "Reliability Assessment of Methylthioadenosine Phosphorylase Immunohistochemistry as a Surrogate Biomarker for CDKN2A Homozygous Deletion in Adult-type IDH-mutant Diffuse Gliomas." Journal of Neuropathology and Experimental Neurology 83, no. 2 (2024): 107. https://doi.org/10.1093/jnen/nlad109.
MLA (9th ed.) CitationF, Gundogdu, et al. "Reliability Assessment of Methylthioadenosine Phosphorylase Immunohistochemistry as a Surrogate Biomarker for CDKN2A Homozygous Deletion in Adult-type IDH-mutant Diffuse Gliomas." Journal of Neuropathology and Experimental Neurology, vol. 83, no. 2, 2024, p. 107, https://doi.org/10.1093/jnen/nlad109.